Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man

Free Radic Biol Med. 2003 Oct 15;35(8):922-8. doi: 10.1016/s0891-5849(03)00433-7.

Abstract

Cholesterol oxidation products, oxysterols, are thought to play a part in the initiation and development of human atherosclerotic lesions. Excessive body iron has been suggested to promote atherosclerosis and coronary heart disease through its pro-oxidative properties. In the present study, the associations between serum ferritin and plasma oxysterol concentrations were examined in 669 eastern Finnish men. Serum ferritin concentration had statistically significant (p <.05) direct correlations with most of the measured oxysterols. In multivariate adjusted regression models, serum ferritin concentration predicted significantly the levels of 27-hydroxycholesterol (beta = 0.13, p <.001), 7alpha-hydroxycholesterol (beta = 0.11, p =.005), 25-hydroxycholesterol (beta = 0.10, p =.007), 7-ketocholesterol (beta = 0.10, p =.009), and 7beta-hydroxycholesterol (beta = 0.10, p =.02). In conclusion, excess body iron, as assessed by serum ferritin, is associated with increased levels of circulating oxysterols, both of enzymatic and nonenzymatic origin, in man.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Cholesterol / blood*
  • Fatty Acids / blood
  • Ferritins / blood*
  • Humans
  • Hydroxycholesterols / blood
  • Male
  • Middle Aged
  • Oxidation-Reduction

Substances

  • Fatty Acids
  • Hydroxycholesterols
  • 27-hydroxycholesterol
  • 25-hydroxycholesterol
  • Ferritins
  • Cholesterol